PharmaVOICE Blog Post

The Future of RWE Technology – Moving Beyond Rapid Cycle Analytics

Posted By: Dan Limbach
August 7, 2017

In recent years, a plethora of real-world evidence (RWE) analytic platforms have emerged, giving researchers the ability to submit analysis parameters, execute analytic programs across specific data sources, and produce rapid results without custom programming.

These RWE platforms facilitate shortened analysis cycle times, delivering results in minutes or hours, instead of days, weeks, or longer. Although these new platforms have created increased analytic efficiency, many are proprietary, forcing RWE organizations to select one technology solution, or manually mediate workflows and analysis results across multiple disparate solutions.

As these platforms increase in number, complexity, and availability, they contribute to a fragmented RWE environment; the Life Science industry is grappling with how to deal with the current disruptive ecosystem.

Stephanie Reisinger, President and General Manager, Evalytica at Evidera, has written an informative paper on how RWE technology is evolving, as well as the future of evidence generation.

This paper covers:
• The current RWE environment – fragmented and evolving
• The explosion of generated data
• The patchwork of current analytic capabilities
• Evidence generation as a “Shared Service”
• The state of real-world data standards
• The future of evidence generation

The paper also cites numerous other works which can provide a deeper dive into this topic.

Read the full document on this topic http://bit.ly/RWE-Evidera

About the Author:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK